Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laxmi Parida

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
Msystems|March 17, 2021
EMPress Enables Tree-Guided, Interactive, and Exploratory Analyses of Multi-omic Data SetsKalen Cantrell, Marcus W Fedarko, Gibraan Rahman, et al.
Cancer Discovery|November 18, 2020
The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses FerroptosisXin Hong, Whijae Roh, Ryan J Sullivan, et al.
Cancer Discovery|November 2, 2023
Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA MutationsAndreas Varkaris, Ferran Fece de la Cruz, Elizabeth E Martin, et al.
Nature Cancer|June 3, 2026
Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastomaJack Y Ghannam, Julian Bryan, Jakob Weiss, et al.
Nature Cancer|June 12, 2026
Publisher Correction: Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastomaJack Y Ghannam, Julian Bryan, Jakob Weiss, et al.
Medrxiv : the Preprint Server for Health Sciences|November 25, 2020
Microbial context predicts SARS-CoV-2 prevalence in patients and the hospital built environmentClarisse Marotz, Pedro Belda-Ferre, Farhana Ali, et al.
Microbiome|June 9, 2021
SARS-CoV-2 detection status associates with bacterial community composition in patients and the hospital environmentClarisse Marotz, Pedro Belda-Ferre, Farhana Ali, et al.
Cancer Discovery|July 27, 2022
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung CancerAshish Noronha, Nishanth Belugali Nataraj, Joo Sang Lee, et al.
Biorxiv : the Preprint Server for Biology|August 26, 2020
Bacterial modification of the host glycosaminoglycan heparan sulfate modulates SARS-CoV-2 infectivityCameron Martino, Benjamin P Kellman, Daniel R Sandoval, et al.
Nature|November 8, 2023
Latent human herpesvirus 6 is reactivated in CAR T cellsCaleb A Lareau, Yajie Yin, Katie Maurer, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
Msystems|March 17, 2021
EMPress Enables Tree-Guided, Interactive, and Exploratory Analyses of Multi-omic Data SetsKalen Cantrell, Marcus W Fedarko, Gibraan Rahman, et al.
Cancer Discovery|November 18, 2020
The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses FerroptosisXin Hong, Whijae Roh, Ryan J Sullivan, et al.
Cancer Discovery|November 2, 2023
Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA MutationsAndreas Varkaris, Ferran Fece de la Cruz, Elizabeth E Martin, et al.
Nature Cancer|June 3, 2026
Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastomaJack Y Ghannam, Julian Bryan, Jakob Weiss, et al.
Nature Cancer|June 12, 2026
Publisher Correction: Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastomaJack Y Ghannam, Julian Bryan, Jakob Weiss, et al.
Medrxiv : the Preprint Server for Health Sciences|November 25, 2020
Microbial context predicts SARS-CoV-2 prevalence in patients and the hospital built environmentClarisse Marotz, Pedro Belda-Ferre, Farhana Ali, et al.
Microbiome|June 9, 2021
SARS-CoV-2 detection status associates with bacterial community composition in patients and the hospital environmentClarisse Marotz, Pedro Belda-Ferre, Farhana Ali, et al.
Cancer Discovery|July 27, 2022
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung CancerAshish Noronha, Nishanth Belugali Nataraj, Joo Sang Lee, et al.
Biorxiv : the Preprint Server for Biology|August 26, 2020
Bacterial modification of the host glycosaminoglycan heparan sulfate modulates SARS-CoV-2 infectivityCameron Martino, Benjamin P Kellman, Daniel R Sandoval, et al.
Nature|November 8, 2023
Latent human herpesvirus 6 is reactivated in CAR T cellsCaleb A Lareau, Yajie Yin, Katie Maurer, et al.
Pageof 13